Liufang Gu

1.3k total citations
22 papers, 371 citations indexed

About

Liufang Gu is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Liufang Gu has authored 22 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Hematology. Recurrent topics in Liufang Gu's work include Acute Myeloid Leukemia Research (8 papers), CAR-T cell therapy research (4 papers) and Immune Cell Function and Interaction (3 papers). Liufang Gu is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), CAR-T cell therapy research (4 papers) and Immune Cell Function and Interaction (3 papers). Liufang Gu collaborates with scholars based in China, Switzerland and United States. Liufang Gu's co-authors include Yinxia Chen, Xing-Mei Cao, Fangxia Wang, Wanhong Zhao, Wanggang Zhang, Aili He, Pengyu Zhang, Bo Lei, Yilin Zhang and Jie Liu and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Science.

In The Last Decade

Liufang Gu

21 papers receiving 364 citations

Peers

Liufang Gu
Juying Wei China
Xing-Mei Cao China
Andrea Quaiser Germany
Agata Pastorczak Poland
Sebastian Klobuch Germany
Huda Salman United States
Adi Nagler Israel
Daniel H. Li United States
Miki Ando Japan
Nicholas A. Zorko United States
Juying Wei China
Liufang Gu
Citations per year, relative to Liufang Gu Liufang Gu (= 1×) peers Juying Wei

Countries citing papers authored by Liufang Gu

Since Specialization
Citations

This map shows the geographic impact of Liufang Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liufang Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liufang Gu more than expected).

Fields of papers citing papers by Liufang Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liufang Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liufang Gu. The network helps show where Liufang Gu may publish in the future.

Co-authorship network of co-authors of Liufang Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Liufang Gu. A scholar is included among the top collaborators of Liufang Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liufang Gu. Liufang Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yuyan, Yuping Sun, S. Yang, et al.. (2023). 132P A phase I clinical trial of QLS31905 in advanced solid tumors. Immuno-Oncology Technology. 20. 100604–100604. 6 indexed citations
2.
Liu, Hailing, Yuqiang Ji, Xiaorong Ma, et al.. (2021). Effects of CpG oligodeoxynucleotides on the differentiation of Treg/Th17 cells. Molecular Immunology. 132. 199–208. 10 indexed citations
3.
Wang, Baiyan, Jie Liu, Wanhong Zhao, et al.. (2020). Chimeric Antigen Receptor T Cell Therapy in the Relapsed or Refractory Multiple Myeloma with Extramedullary Disease--a Single Institution Observation in China. Blood. 136(Supplement 1). 6–6. 16 indexed citations
4.
Chen, Hongli, Fangxia Wang, Pengyu Zhang, et al.. (2019). Management of cytokine release syndrome related to CAR-T cell therapy. Frontiers of Medicine. 13(5). 610–617. 77 indexed citations
5.
Gu, Liufang, et al.. (2018). Pellino-1 Protects Periodontal Ligament Stem Cells Against H2O2-Induced Apoptosis via Activation of NF-κB Signaling. Molecular Biotechnology. 60(8). 533–538. 8 indexed citations
6.
7.
Fan, Frank, Wanhong Zhao, Jie Liu, et al.. (2017). Durable remissions with BCMA-specific chimeric antigen receptor (CAR)-modified T cells in patients with refractory/relapsed multiple myeloma.. Journal of Clinical Oncology. 35(18_suppl). LBA3001–LBA3001. 54 indexed citations
8.
Fan, Frank, Wanhong Zhao, Jie Liu, et al.. (2017). Durable remissions with BCMA-specific chimeric antigen receptor (CAR)-modified T cells in patients with refractory/relapsed multiple myeloma.. Journal of Clinical Oncology. 35(15_suppl). LBA3001–LBA3001. 62 indexed citations
9.
Feng, Yuandong, Ying Shen, Hongli Chen, et al.. (2017). Expression profile analysis of long non‐coding RNA in acute myeloid leukemia by microarray and bioinformatics. Cancer Science. 109(2). 340–353. 34 indexed citations
10.
11.
Wang, Fangxia, Wanggang Zhang, Aili He, et al.. (2016). Effect of granulocyte colony-stimulating factor priming combined with low-dose cytarabine and homoharringtonine in higher risk myelodysplastic syndrome patients. Leukemia Research. 48. 57–61. 6 indexed citations
12.
Ma, Xiaorong, Jin Wang, Wanggang Zhang, et al.. (2015). [Cohort Study on GHA and New Combined Priming Chemotherapeutic Regimens in Treatment of Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome].. PubMed. 23(2). 369–74. 2 indexed citations
13.
Zhao, Jianqiang, et al.. (2014). Investigation of a novel biomarker, neuropilin-1, and its application for poor prognosis in acute myeloid leukemia patients. Tumor Biology. 35(7). 6919–6924. 8 indexed citations
14.
Li, Jing, Ju Bai, Liufang Gu, et al.. (2014). Prediction and identification of HLA-A*0201-restricted epitopes from leukemia-associated protein MLAA-22 which elicit cytotoxic T lymphocytes. Medical Oncology. 31(12). 293–293. 2 indexed citations
15.
Zhang, Wenjuan, Wanggang Zhang, Pengyu Zhang, et al.. (2012). The expression and functional characterization associated with cell apoptosis and proteomic analysis of the novel gene MLAA-34 in U937 cells. Oncology Reports. 29(2). 491–506. 8 indexed citations
16.
17.
Zhao, Jianqiang, et al.. (2011). Quantitative assessment of MLAA-34 expression in diagnosis and prognosis of acute monocytic leukemia. Cancer Immunology Immunotherapy. 60(4). 587–597. 9 indexed citations
18.
Gu, Liufang, Fangxia Wang, Xing-Mei Cao, et al.. (2010). Low dose of homoharringtonine and cytarabine combined with granulocyte colony-stimulating factor priming on the outcome of relapsed or refractory acute myeloid leukemia. Journal of Cancer Research and Clinical Oncology. 137(6). 997–1003. 21 indexed citations
19.
Ji, Yuqiang, Wanggang Zhang, Jin Wang, & Liufang Gu. (2010). mRNA expression of the XAGE-1 gene in human acute leukemia. International Journal of Hematology. 91(2). 209–212. 2 indexed citations
20.
Jahan, Thierry, Liufang Gu, Robert A. Kratzke, et al.. (2006). Vatalanib (V) for patients with previously untreated advanced malignant mesothelioma (MM): A phase II study by the Cancer and Leukemia Group B (CALGB 30107). Journal of Clinical Oncology. 24(18_suppl). 7081–7081. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juying Wei Breakdown of academic impact, for papers by Xing-Mei Cao Breakdown of academic impact, for papers by Andrea Quaiser Breakdown of academic impact, for papers by Agata Pastorczak Breakdown of academic impact, for papers by Sebastian Klobuch Breakdown of academic impact, for papers by Huda Salman Breakdown of academic impact, for papers by Adi Nagler Breakdown of academic impact, for papers by Daniel H. Li Breakdown of academic impact, for papers by Miki Ando Breakdown of academic impact, for papers by Nicholas A. Zorko
Rankless by CCL
2026